Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy

Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy

The prognostic significance of glandular differentiation in urothelial carcinoma (UC) is controversial, and thus far there is no established treatment strategy against metastasis of glandular component. We describe here a case of metastatic UC with glandular differentiation that had histological dis...

Full description

Bibliographic Details
Main Authors: Taku Naiki, Toshiki Etani, Aya Naiki-Ito, Kana Fujii, Ryosuke Ando, Keitaro Iida, Takashi Nagai, Yosuke Sugiyama, Motoo Nakagawa, Noriyasu Kawai, Takahiro Yasui
Format: Article
Language:English
Published: Karger Publishers 2017-11-01
Series:Case Reports in Oncology
Subjects:
Urothelial carcinoma with glandular differentiation
Bladder
mFOLFOX6 plus bevacizumab chemotherapy
Online Access:https://www.karger.com/Article/FullText/484597

Internet

https://www.karger.com/Article/FullText/484597

Similar Items